ARCHIVES

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

This article is from The Cancer Letter archive.

Vol. 02 No. 15 | April 9, 1976

Download PDF Visit The Full Archive

Related Articles

More Bad News for AVEO As Tivozanib Partner Bids Adieu

May 31, 2013

In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident

April 30, 1976

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Drug Development Gets Extra $500,000

November 18, 1977

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010